IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 203 filers reported holding IMMUNOGEN INC in Q4 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,324,579 | -1.1% | 3,108,039 | +17.6% | 0.02% | 0.0% |
| Q2 2023 | $49,864,616 | +406526.6% | 2,642,534 | -17.3% | 0.02% | +240.0% |
| Q1 2023 | $12,263 | +91.9% | 3,193,514 | +147.9% | 0.01% | +150.0% |
| Q4 2022 | $6,390 | -99.8% | 1,288,180 | +97.0% | 0.00% | +100.0% |
| Q3 2022 | $3,126,000 | -27.5% | 654,039 | -31.8% | 0.00% | -50.0% |
| Q2 2022 | $4,313,000 | -54.2% | 958,551 | -56.2% | 0.00% | -33.3% |
| Q1 2022 | $9,417,000 | +98.4% | 2,190,057 | +182.6% | 0.00% | +200.0% |
| Q4 2021 | $4,747,000 | -1.4% | 774,966 | -6.6% | 0.00% | 0.0% |
| Q3 2021 | $4,814,000 | -18.4% | 830,023 | -7.3% | 0.00% | -50.0% |
| Q2 2021 | $5,898,000 | -20.0% | 894,915 | -1.7% | 0.00% | 0.0% |
| Q1 2021 | $7,377,000 | +32.8% | 910,771 | +5.8% | 0.00% | 0.0% |
| Q4 2020 | $5,553,000 | +84.9% | 860,912 | +3.2% | 0.00% | +100.0% |
| Q3 2020 | $3,003,000 | -32.7% | 834,303 | -13.9% | 0.00% | -50.0% |
| Q2 2020 | $4,460,000 | -0.5% | 969,523 | -26.3% | 0.00% | 0.0% |
| Q1 2020 | $4,484,000 | +34.3% | 1,315,006 | +101.1% | 0.00% | +100.0% |
| Q4 2019 | $3,338,000 | +100.1% | 653,757 | -5.1% | 0.00% | 0.0% |
| Q3 2019 | $1,668,000 | +8.9% | 688,945 | -2.4% | 0.00% | 0.0% |
| Q2 2019 | $1,532,000 | +719.3% | 705,551 | +921.0% | 0.00% | 0.0% |
| Q1 2019 | $187,000 | -43.7% | 69,102 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $332,000 | -49.2% | 69,102 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $654,000 | +8.5% | 69,102 | +11.5% | 0.00% | -25.0% |
| Q2 2018 | $603,000 | -7.5% | 61,949 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $652,000 | +64.2% | 61,949 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $397,000 | -16.2% | 61,949 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $474,000 | +3.0% | 61,949 | -4.3% | 0.00% | 0.0% |
| Q2 2017 | $460,000 | +72.3% | 64,749 | -6.1% | 0.00% | +50.0% |
| Q1 2017 | $267,000 | +86.7% | 68,928 | -1.6% | 0.00% | +100.0% |
| Q4 2016 | $143,000 | -23.9% | 70,023 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $188,000 | -13.4% | 70,323 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $217,000 | -63.9% | 70,323 | -0.4% | 0.00% | -66.7% |
| Q1 2016 | $601,000 | +264.2% | 70,588 | +479.7% | 0.00% | +200.0% |
| Q4 2015 | $165,000 | +38.7% | 12,177 | -2.0% | 0.00% | 0.0% |
| Q3 2015 | $119,000 | -33.5% | 12,424 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $179,000 | +57.0% | 12,424 | -2.2% | 0.00% | 0.0% |
| Q1 2015 | $114,000 | +46.2% | 12,705 | 0.0% | 0.00% | – |
| Q4 2014 | $78,000 | -43.9% | 12,705 | -3.0% | 0.00% | -100.0% |
| Q3 2014 | $139,000 | -10.3% | 13,094 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $155,000 | -20.5% | 13,094 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $195,000 | +1.6% | 13,094 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $192,000 | -10.3% | 13,094 | +4.1% | 0.00% | 0.0% |
| Q3 2013 | $214,000 | -79.2% | 12,584 | -79.7% | 0.00% | -85.7% |
| Q2 2013 | $1,029,000 | – | 62,075 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |